Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.92 USD | +3.07% | +1.71% | +126.05% |
Apr. 29 | Stoke Therapeutics Appoints Thomas Leggett CFO | MT |
Apr. 29 | Stoke Therapeutics, Inc. Announces Executive Changes, Effective May 7, 2024 | CI |
Financials (USD)
Sales 2024 * | 12.37M | Sales 2025 * | 15.76M | Capitalization | 602M |
---|---|---|---|---|---|
Net income 2024 * | -116M | Net income 2025 * | -138M | EV / Sales 2024 * | 32.7 x |
Net cash position 2024 * | 199M | Net cash position 2025 * | 146M | EV / Sales 2025 * | 28.9 x |
P/E ratio 2024 * |
-5.01
x | P/E ratio 2025 * |
-4.58
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.42% |
1 day | +4.81% | ||
1 week | -0.86% | ||
Current month | +4.81% | ||
1 month | -14.31% | ||
3 months | +136.40% | ||
6 months | +183.33% | ||
Current year | +119.77% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Kaye
CEO | Chief Executive Officer | 74 | 17-09-30 |
Isabel Aznarez
FOU | Founder | 52 | 14-05-31 |
Stephen Tulipano
DFI | Director of Finance/CFO | 65 | 19-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 15-08-31 |
Edward Kaye
CEO | Chief Executive Officer | 74 | 17-09-30 |
Seth Harrison
CHM | Chairman | 63 | 15-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 11.81 | +2.16% | 196 682 |
24-05-01 | 11.56 | +4.81% | 924,333 |
24-04-30 | 11.03 | -7.00% | 762,834 |
24-04-29 | 11.86 | -4.43% | 936,133 |
24-04-26 | 12.41 | +6.16% | 896,225 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.77% | 602M | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- STOK Stock